Capital Nephrology Associates, PA — Cary, North Carolina

Capital Nephrology Associates, PA is a clinical research site located in Cary, North Carolina, United States 27511.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Capital Nephrology Associates, PA has participated in 1 clinical trials.

Therapeutic areas: Hyperkalemia.

Sponsors: Ardelyx.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cary

Browse all research sites in North Carolina · View every site in Cary

• Duke University Medical Center
• WakeMed Health & Hospitals
• Waverly Hematology Oncology
• Duke Cancer Center Cary
• GSK Investigational Site
• Pfizer Investigational Site
• PMG Research of Cary
• Research Site
• PMG Research of Raleigh, LLC d/b/a PMG Research of Cary
• UNC Health Cancer Care Cary
• North Carolina Retina Associates
• Accellacare - Cary

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Capital Nephrology Associates, PA?

Capital Nephrology Associates, PA has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Capital Nephrology Associates, PA conducted?

Capital Nephrology Associates, PA has 1 clinical trials on record. Their work covers Hyperkalemia.

Is Capital Nephrology Associates, PA accredited by Crixeo Clinical Trials?

Capital Nephrology Associates, PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Capital Nephrology Associates, PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.